SCHEMBL9019796

SCHEMBL9019796

CC(=O)Nc1ncc2c(ncn2COC(CO)CO)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
NFKB1 P19838 1/20 0.41
BLM P54132 1/20 0.41
VCP P55072 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
PDE3A Q14432 1/20 0.35
TKT P29401 1/20 0.33
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
CYP1A2 P05177 1/20 0.31
ADA P00813 1/20 0.31
TSHR P16473 1/20 0.30
CCR4 P51679 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9019764 0.92 PDE3A (0.38) CYP3A4MEN1KMT2AALDH1A1LMNA
SCHEMBL9019807 0.88 PDE3A (0.32) CYP3A4MEN1KMT2AALDH1A1LMNA
SCHEMBL9019826 0.88 ALDH1A1 (0.37) CYP3A4MEN1KMT2AALDH1A1LMNA
SCHEMBL9845278 0.87 SYK (0.31) CYP3A4MEN1KMT2ACYP2D6CYP2C9
SCHEMBL9019788 0.83 ACACB (0.37) MEN1KMT2AALDH1A1LMNA
SCHEMBL9845272 0.83 CYP3A4 (0.35) CYP3A4MEN1KMT2ALMNASMN1; SMN2
SCHEMBL9845265 0.82 TSHR (0.40) MEN1KMT2ABLMTKTCYP1A2
SCHEMBL9845279 0.81 MEN1 (0.39) MEN1KMT2ASMN1; SMN2TKTTSHR
SCHEMBL6992185 0.81 TKT (0.35) CYP3A4MEN1KMT2AALDH1A1LMNA
SCHEMBL965011 0.79 ALDH1A1 (0.46) CYP3A4MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed